1.
Diagn Microbiol Infect Dis
; 64(1): 80-2, 2009 May.
Article
in English
| MEDLINE
| ID: mdl-19304434
ABSTRACT
Hepatitis B reactivation in hepatitis B surface antigen (HBsAg)-negative and anti-HBsAg antibodies-positive patients is an infrequent complication of chemotherapy, usually with fatal evolution. Here we report an HBsAg-negative patient with a myelodysplastic syndrome, who developed hepatitis B reactivation after chemotherapy and evolved favorably after lamivudine treatment, allowing seroconversion.